NasdaqGS:PODDMedical Equipment
Is Insulet (PODD) A Bargain Following Its Calm Partnership?
Insulet (PODD) stock is drawing attention after the company announced a global partnership with Calm to offer free mindfulness and sleep resources tailored to people living with diabetes and their caregivers.
See our latest analysis for Insulet.
The Calm partnership lands at a time when Insulet's recent 30 day share price return of 4.27% contrasts with a year to date decline of 41.68% and a 1 year total shareholder return decline of 43.55%. This suggests short term momentum has picked up...